Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Imperial and UCL to open Future Cities Centre

11 November 2011

UCL, Imperial College London and Cisco have entered into a three year agreement to create a Future Cities Centre in London - part of the Tech City cluster announced by David Cameron yesterday. Read: Wired, More: BBC News Online, Daily Telegraph, Evening Standard, UCL news story